The Milner Therapeutics Institute is a global therapeutic alliance based in Cambridge, dedicated to the conversion of basic science into therapies. Its mission is to foster close collaborative interactions between academia and industry to accelerate medical advancement. The Institute represents a new 'open borders' paradigm, with no physical boundaries and a flexible operational model.

The Affiliated Partners programme is composed of companies, such as service and product providers, that are developing tools to advance therapeutic needs. The Institute coordinates interactions between affiliated companies and academic, pharmaceutical or biotechnology partners, with the aim of making a cohesive therapeutically mixed community. Affiliation to the Institute provides networking and advertising opportunities and fast exchange of information and know-how. There are currently 29 Affiliated Partners.